S37 Endocrine Health Disparities in Unusual Situations

Program: Symposia
Clinical Session
Saturday, April 2, 2016: 4:45 PM-6:15 PM
Room 205 (BCEC)
Chair:
Gilberto J. Paz-Filho, MD, The Australian National University, Canberra, Australia

Nothing to Disclose: GJP
4:45 PM
Rocio Ines Pereira, MD, Division of Endocrinology, Metabolism and Diabetes, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO
Nothing to Disclose: RIP
5:15 PM
Vivian A Fonseca, MD, Section of Endocrinology, Tulane University Health Science, New Orleans, LA
Nothing to Disclose: VAF
5:45 PM
Nizar Albache, MD, internal Medicine, Aleppo University Hospital, Aleppo, Syria
Nothing to Disclose: NA
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire